FDAClass IINovember 3, 2021

Atellica CH Urinary/Cerebrospinal Fluid Protein recall

Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11097543

Why was Atellica CH Urinary/Cerebrospinal Fluid Protein recalled?

The firm has confirmed the potential for Atellica CH Urinary/Cerebrospinal Fluid Protein reagent carryover impacting Enzymatic Hemoglobin A1c (A1c_E and A1c_EM) results. Falsely depressed Enzymatic Hemoglobin A1c results may affect consideration of intervention.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

All lots impacted

Product
Atellica CH Urinary/Cerebrospinal Fluid Protein (UCFP), SMN 11097543
Recalling firm
Siemens Healthcare Diagnostics, Inc.
Quantity
1402 (US); 2941 (OUS)
Distribution
Worldwide distribution - US Nationwide distribution.
Recall date
November 3, 2021
Classification
Class II
Status
Ongoing
Agency
FDA (device)
Open FDA enforcement record Latest recalls